Evidence map›Paper›PMID 34956923›Full record

ArticleEuropean thyroid journal2021

Cardiac Metastasis from Medullary Thyroid Cancers with Long-Term Survival under Vandetanib.

Camille Buffet, Sophie Leboulleux, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Laure Cabanes, Anthony Dohan, Pascal Leprince, Martin Schlumberger, Olivier Huillard, Lionel Groussin

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in European thyroid journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Camille BuffetDepartment of Thyroid Pathologies and Endocrine Tumors, AP-HP, Pitié-Salpêtrière Hospital, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, Sorbonne Université, Paris, France.
Sophie LeboulleuxDepartment of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institut, Villejuif, France.
Françoise Kraeber-BodéréNuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France.
Caroline Bodet-MilinNuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France.
Laure CabanesDepartment of Cardiology, APHP, Cochin Hospital, Paris, France.
Anthony DohanRadiology Department, Université de Paris, Paris, France.
Pascal LeprinceDepartment of Thoracic and Cardiovascular Surgery, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Martin SchlumbergerUMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France.
Olivier HuillardUniversité de Paris, Sorbonne Paris Cité, Paris, France.
Lionel GroussinINSERM Unité 1016, CNRS UMR 8104, Institut Cochin, Paris, France.
Centre National de la Recherche Scientifique · FRUniversité Paris Cité · FRInstitut Gustave Roussy · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac metastases from thyroid cancers are uncommon with a poor prognosis. There is a lack of long-term follow-up studies. CASES: We report 2 cases of cardiac metastasis from medullary thyroid cancer (MTC). Both patients presented limited metastatic disease apart from a cardiac metastasis. The initial diagnosis was challenging and was facilitated by functional imaging with an immuno-PET-CT using an anti-CEA bispecific antibody and a

conclusionThese cases illustrate long-term survival and effectiveness of clinical management of 2 patients who developed cardiac metastases from MTC, in the current era of personalized medicine with targeted therapy.

Indexed as

Cardiac metastasisMedullary thyroid cancersRearranged during transfection inhibitorsRearranged during transfection mutationVandetanib

Identifiers

PMID34956923
PMCPMC8647102
OpenAlexW3195074420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.